Cyclin-dependent kinase 9 may as a novel target in downregulating the atherosclerosis inflammation (Review).
about
Serum cyclin-dependent kinase 9 is a potential biomarker of atherosclerotic inflammation.Down-regulating cyclin-dependent kinase 9 of alloreactive CD4+ T cells prolongs allograft survival.miR-206 inhibits the growth of hepatocellular carcinoma cells via targeting CDK9.Ensemble-based modeling and rigidity decomposition of allosteric interaction networks and communication pathways in cyclin-dependent kinases: Differentiating kinase clients of the Hsp90-Cdc37 chaperone.
P2860
Cyclin-dependent kinase 9 may as a novel target in downregulating the atherosclerosis inflammation (Review).
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cyclin-dependent kinase 9 may ...... lerosis inflammation (Review).
@ast
Cyclin-dependent kinase 9 may ...... lerosis inflammation (Review).
@en
Cyclin-dependent kinase 9 may ...... e atherosclerosis inflammation
@nl
type
label
Cyclin-dependent kinase 9 may ...... lerosis inflammation (Review).
@ast
Cyclin-dependent kinase 9 may ...... lerosis inflammation (Review).
@en
Cyclin-dependent kinase 9 may ...... e atherosclerosis inflammation
@nl
prefLabel
Cyclin-dependent kinase 9 may ...... lerosis inflammation (Review).
@ast
Cyclin-dependent kinase 9 may ...... lerosis inflammation (Review).
@en
Cyclin-dependent kinase 9 may ...... e atherosclerosis inflammation
@nl
P2093
P2860
P356
P1433
P1476
Cyclin-dependent kinase 9 may ...... lerosis inflammation (Review).
@en
P2093
P2860
P304
P356
10.3892/BR.2014.322
P577
2014-07-31T00:00:00Z